🇺🇸 Zoplicone in United States
528 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 528
Most-reported reactions
- Fatigue — 64 reports (12.12%)
- Nausea — 61 reports (11.55%)
- Off Label Use — 57 reports (10.8%)
- Diarrhoea — 56 reports (10.61%)
- Vomiting — 55 reports (10.42%)
- Depression — 51 reports (9.66%)
- Pain — 51 reports (9.66%)
- Headache — 48 reports (9.09%)
- Malaise — 45 reports (8.52%)
- Dizziness — 40 reports (7.58%)
Other Other approved in United States
Frequently asked questions
Is Zoplicone approved in United States?
Zoplicone does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Zoplicone in United States?
Brasilia University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.